 | Up a level |
Rajeev, Surya, Roberts, Carl 
ORCID: 0000-0003-4275-601X, Brown, Emily, Sprung, Victoria ORCID: 0000-0002-2666-4986, Harrold, Jo ORCID: 0000-0002-0899-4586, Halford, Jason ORCID: 0000-0003-1629-3189, Stancak, Andrej ORCID: 0000-0003-3323-3305, Boyland, Emma ORCID: 0000-0001-8384-4994, Kemp, Graham ORCID: 0000-0002-8324-9666, Perry, Julie et al (show 4 more authors)
(2023)
No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, cross-over trial (ENERGIZE).
Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 25 (12).
pp. 3621-3631.